AGP Picks
View all

Business Insider North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Insider North Carolina.

Press releases published on October 15, 2026

Salvia BioElectronics Initiates Pivotal Study with First Patient in the U.S. Receiving Ultra Thin Neuromodulation Implant for Resistant Migraine
Eindhovens medtechbedrijf Salvia BioElectronics start grootschalige studie in de VS met flinterdunne implantaten tegen migraine
R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026
Ohalo becomes DataXray, adopting the name its customers already use
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes
Why Is Weight Loss Different During Menopause? Common Myths Debunked
illumin Holdings Inc. announces date for third quarter 2026 financial and operating results
Understanding Spreads, Fees and Overnight Costs in CFD Trading
Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
PlaneSense to equip entire fleet of PC-12 turboprops and PC-24 Jets with Gogo Galileo connectivity
Southern Saskatchewan farmers getting ready to round up pesticides and livestock medications for Fall collection events
Flagship Communities Real Estate Investment Trust Announces Sixth Consecutive Cash Distribution Increase
Halcones Precious Metals Announces AGM Results and Closing of First Tranche of Private Placement
First Advantage to Release Third Quarter 2026 Financial Results and Hold Investor Conference Call on November 5, 2026
INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS
Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab
Rethink s’associe à Joe Fresh(MC) et à la Fondation Pharmaprix pour la santé des femmes(MC)
Rethink Partners with Joe Fresh™ & Shoppers Foundation for Women's Health™
 Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Business Insider North Carolina

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.